Without a change of behavior, antibiotic resistance is an increasingly serious threat to global public health, posing a ‘catastrophic threat’ that could return us to an era where deaths due to common infections are rife. Be aware, be educated, be responsible and support actions to ensure that future generations can enjoy modern medical advances made possible through keeping bacterial infections at bay through the effective use of antibiotics says Instinctif Partners.
Instinctif Partners has built an impressive Public Policy offering with notable expertise in pharma and medtech across its teams in the UK (London) and the EU (Brussels). With the acquisition of Brand Associates, this experience is extended to Germany (Berlin). Brand’s clients in the Life Sciences sector include Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Lilly Deutschland and PhRMA. Read more
College Group (including leading brands College Hill, The College, College Public Policy, Policy Action, Green Issues Communique, Stockheim Media and Instinctif) is rebranding and unifying its business operations under one single brand – Instinctif Partners.
We have also moved to our new London headquarters at 65 Gresham Street, London, EC2V 7NQ.
Since the start of 2013, the market for IPOs on NASDAQ has been very buoyant. With little activity over the past few years, it has been a welcome change by many biotech companies that have taken advantage of the opening of the funding window to list on NASDAQ including our client Prosensa Holding N.V.
BIO International Congress, April 22-25 2013, Chicago, USA
In its twentieth year, BIO is the biggest event in the life science sector. Senior Account Director Stefanie Bacher and Junior Account Director Dr Anastasios Koutsos represented College Hill at the conference, reporting a whirlwind experience, which could be summarized under the motto “think big”. An exhibit hall floor of 2,670,000 sq ft alone, the size of four football fields, 15,000 attendees from all over the world and the amount of energy was impressive to say the least. Recapping information from 125+breakout sessions, 800+ speeches, 6 super sessions and a couple of keynotes seems like a mission impossible. After digesting the event, here are their ‘top 10’ highlights...
College Hill Life Sciences congratulates all the nominees shortlisted for the European Mediscience Awards 2013, especially those individuals and companies in the category, Commentator of the Year, of which College Hill is the sponsor.
Of College Hill Life Sciences own clients, congratulations go to Clinigen Group (Transaction of the year, Emerging Company), Imperial Innovations (Most Significant Contribution), and Oxford Gene Technology (Emerging Star).
In March College Hill Life Sciences’ ASX-listed client Mesoblast closed AU$170 million (US$176 million) in a private placing with institutional investors. Based on BioWorld’s Insight report issued early March, this is the largest Life Sciences private financing of a public company globally of 2013, just pipping the amounts raised by US-based Ironwood Pharmaceuticals (NASDAQ) and OPKO Health Inc. (NYSE) in January. AIM-listed client, e-Therapeutics, which raised £40 million (US$63m) from an issue of new shares in February, would place it as the fifth largest financing according to figures in the BioWorld report.
The Life Sciences team of College Hill, part of the international business communications consultancy, College Group, has continued to add to its portfolio of clients with six new client wins to date in 2013 from across both Europe and Australia. New clients include both private and listed companies, with mandates ranging from fully retained services to branding and IR/PR projects.
The Life Sciences team of College Hill, part of the international business communications consultancy, College Group, has strengthened and expanded its Investors Relations and Financial PR offering with the appointment of Veronica Sellar as Partner.
College Hill supported Clinigen Group plc in its Admission to AIM on the London Stock Exchange – the first IPO in the pharma/biotech sector on AIM in five years. The team provided strategic financial PR advice, media training, prepared materials and implemented the PR campaign around the Intention to Float, Pricing announcements and design of Prospectus.
Following the successful workshop on social media in the life sciences held in Melbourne in May 2012, Sue Charles and Douglas Pretsell were again on stage sharing their experience of effective media management during a half day training session organised by AusBiotech, Australia’s biotech trade association.
The Life Sciences team is a core sponsor of the Oxford Spin-out Equity Management (OSEM) which runs a series of events every year. OSEM manages Oxford University's shareholdings in its spin-out companies and seeks ways of maximising the value of its equity stakes. The group has been holding networking and learning events for its portfolio companies and investors in the Oxford area.
College Group has acquired Merlin Financial Communications, a leading London based Financial PR consultancy which will be integrated into our College Hill Capital Markets practice.
This acquisition is very much in line with the delivery of the Group’s ambitious growth strategy of building an international business communications consultancy which meets the increasing requirements of its clients. The Group now acts for over 650 clients globally, including over 10 Fortune 500 corporations.
Although relatively new in Melbourne, College Hill is already well integrated into the local life science scene and was delighted to collaborated with the BioMelbourne Network on a couple of well attended workshops around the use of social media in the life sciences.
With offices on five continents now, College Hill’s newest office is in Australia. Dr Douglas Pretsell of the Life Sciences team has just launched College Hill’s new Melbourne, Australia office in Melbourne’s Central Business District (CBD) at 278 Collins Street. College Hill has had a presence in Australia for a couple of years with Sue Charles, Life Sciences Managing Partner, based part of the year in Sydney.